LU78951A1 - Nouveau vaccin - Google Patents
Nouveau vaccinInfo
- Publication number
- LU78951A1 LU78951A1 LU78951A LU78951A LU78951A1 LU 78951 A1 LU78951 A1 LU 78951A1 LU 78951 A LU78951 A LU 78951A LU 78951 A LU78951 A LU 78951A LU 78951 A1 LU78951 A1 LU 78951A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- virus
- rabies
- new vaccine
- vaccine
- new
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 241000711798 Rabies lyssavirus Species 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 102000009027 Albumins Human genes 0.000 abstract 1
- 108010088751 Albumins Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 206010037742 Rabies Diseases 0.000 abstract 1
- 210000004748 cultured cell Anatomy 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 210000001161 mammalian embryo Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3258/77A GB1596653A (en) | 1977-01-26 | 1977-01-26 | Vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
LU78951A1 true LU78951A1 (fr) | 1979-09-06 |
Family
ID=9754946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU78951A LU78951A1 (fr) | 1977-01-26 | 1978-01-26 | Nouveau vaccin |
Country Status (20)
Country | Link |
---|---|
US (2) | US4320115A (xx) |
JP (2) | JPS5394084A (xx) |
AT (1) | AT368005B (xx) |
BE (1) | BE863368A (xx) |
CA (1) | CA1112167A (xx) |
CH (2) | CH659084A5 (xx) |
DE (1) | DE2803240B2 (xx) |
DK (1) | DK36378A (xx) |
ES (2) | ES466359A1 (xx) |
FI (1) | FI59812C (xx) |
FR (1) | FR2378859B1 (xx) |
GB (1) | GB1596653A (xx) |
IE (1) | IE46498B1 (xx) |
IT (1) | IT1192756B (xx) |
LU (1) | LU78951A1 (xx) |
NL (1) | NL174371C (xx) |
NO (1) | NO780156L (xx) |
PT (1) | PT67554B (xx) |
SE (2) | SE444453B (xx) |
ZA (1) | ZA78421B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4347239A (en) | 1980-07-30 | 1982-08-31 | Norden Laboratories, Inc. | Inactivated rabies vaccine for veterinary use |
US4429045A (en) | 1980-07-30 | 1984-01-31 | Norden Laboratories, Inc. | Rabies virus adapted for growth in swine testicle cell culture |
EP0100752A3 (de) * | 1982-08-04 | 1985-04-17 | Veterinär-Bakteriologisches Institut der Universität Bern | Verfahren zur Herstellung eines neuen Tollwut-Impfstoffs, Behälter und Mittel zu dessen Verabreichung und Verfahren zur oralen Immunisierung |
JPS6147187A (ja) * | 1984-08-10 | 1986-03-07 | Chemo Sero Therapeut Res Inst | 狂犬病ウイルスの精製方法 |
DE3526809A1 (de) * | 1985-07-26 | 1987-04-02 | Behringwerke Ag | Tollwut-lebendimpfstoff |
CA1249518A (en) * | 1985-09-06 | 1989-01-31 | David Johnston | Oral immunization of mammals |
US7094391B1 (en) * | 1988-10-24 | 2006-08-22 | The University Of Texas System | Compositions and methods for administering Borrelia burgdorferi antigens |
WO1995028175A1 (en) * | 1994-04-19 | 1995-10-26 | Thomas Jefferson University | Viral ribonucleocapsid as an immunological enhancer |
US6495360B1 (en) * | 1999-05-28 | 2002-12-17 | Photogen, Inc. | Method for enhanced protein stabilization and for production of cell lines useful for production of such stabilized proteins |
US20030118628A1 (en) * | 2001-04-05 | 2003-06-26 | Tutuncu Nurhan Pinar | Confectionery product having a salivation region and an oral comfort region |
CN112342185B (zh) * | 2020-11-11 | 2022-12-02 | 深圳市卫光生物制品股份有限公司 | 一种鸡胚细胞狂犬病病毒的生物反应器工艺 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1015262A (en) * | 1962-02-09 | 1965-12-31 | Nat Res Dev | Virus culture |
US3255080A (en) * | 1962-08-06 | 1966-06-07 | Dow Chemical Co | Live rabies virus vaccine and method for the production thereof |
US3397267A (en) * | 1964-09-21 | 1968-08-13 | Research Corp | Method of producing rabies vaccine |
FR1567869A (xx) * | 1967-06-22 | 1969-05-23 | ||
US4014991A (en) * | 1976-01-23 | 1977-03-29 | The United States Of America As Represented By The Department Of Health, Education And Welfare | Oral rabies immunization of carnivores |
-
1977
- 1977-01-26 GB GB3258/77A patent/GB1596653A/en not_active Expired
-
1978
- 1978-01-16 NO NO780156A patent/NO780156L/no unknown
- 1978-01-20 PT PT67554A patent/PT67554B/pt unknown
- 1978-01-20 NL NLAANVRAGE7800708,A patent/NL174371C/xx not_active IP Right Cessation
- 1978-01-20 FI FI780184A patent/FI59812C/fi not_active IP Right Cessation
- 1978-01-23 SE SE7800781A patent/SE444453B/sv not_active IP Right Cessation
- 1978-01-24 ZA ZA00780421A patent/ZA78421B/xx unknown
- 1978-01-24 IE IE161/78A patent/IE46498B1/en not_active IP Right Cessation
- 1978-01-24 CA CA295,550A patent/CA1112167A/en not_active Expired
- 1978-01-25 CH CH1456/86A patent/CH659084A5/de not_active IP Right Cessation
- 1978-01-25 DE DE2803240A patent/DE2803240B2/de not_active Withdrawn
- 1978-01-25 US US05/872,056 patent/US4320115A/en not_active Expired - Lifetime
- 1978-01-25 DK DK36378A patent/DK36378A/da not_active Application Discontinuation
- 1978-01-25 CH CH825/78A patent/CH658192A5/de not_active IP Right Cessation
- 1978-01-25 JP JP715078A patent/JPS5394084A/ja active Granted
- 1978-01-25 AT AT0052678A patent/AT368005B/de not_active IP Right Cessation
- 1978-01-25 IT IT67143/78A patent/IT1192756B/it active
- 1978-01-26 BE BE184675A patent/BE863368A/xx not_active IP Right Cessation
- 1978-01-26 ES ES466359A patent/ES466359A1/es not_active Expired
- 1978-01-26 LU LU78951A patent/LU78951A1/xx unknown
- 1978-01-26 FR FR7802215A patent/FR2378859B1/fr not_active Expired
- 1978-05-17 ES ES469937A patent/ES469937A1/es not_active Expired
-
1981
- 1981-10-13 US US06/310,447 patent/US4400472A/en not_active Expired - Fee Related
-
1982
- 1982-03-19 SE SE8201768A patent/SE443924B/sv not_active IP Right Cessation
- 1982-10-15 JP JP57181202A patent/JPS5877822A/ja active Granted
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7508565L (sv) | Preparat for behandling av infektionssjukdomar forfarande for dess framstellning samt anvendning av dylikt preparat. | |
LU78951A1 (fr) | Nouveau vaccin | |
DK401981A (da) | Herpes simplex type 1 underenhed vaccine og fremgangsmaade til fremstilling deraf | |
IT8148663A0 (it) | Linea di cellule derivate da epato ma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione | |
GB1522006A (en) | Feline calicivirus vaccine and a process for the production thereof | |
SE8105079L (sv) | Antibiotikum bmg162-af2 | |
ES373631A1 (es) | Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret. | |
JPS51130530A (en) | Weed killer also controlling plant growth and compound used | |
JPS57206384A (en) | Cultivating method of cell | |
ATE29213T1 (de) | Mikrobielles haartonikum. | |
FI913266A0 (fi) | Foerfarande foer infoerande av exogen dna i djurets somatiska och groddceller. | |
IT1114284B (it) | Procedimento per mantenere attiva la cultura di fermenti | |
FR1359437A (fr) | Procédé et installation pour la culture artificielle de plantes, bactéries et autres êtres vivants | |
YU46029B (sh) | Postopek za pripravo živega cepiva proti mumpsu | |
GB1547373A (en) | Method of growing plant cells and/or photosynthetic bacteria | |
JPS51115987A (en) | Process for cultivating chlorella | |
JPS54135134A (en) | Shiitake*mushroom* cultivating method and its device by using artificial culture log | |
EP0156478A3 (en) | Propagation of group ii avian adeno (aa) virus in avian cell culture and vaccine produced | |
JPS5775991A (en) | Novel physiologically active substance jcv-80 | |
SU549106A1 (ru) | Способ сохранени отдаленных гибридов | |
JPS5699726A (en) | Production of fully aged artificial seeding wood for cultivating mushroom | |
Boxus | Tissue culture of woody species, a tool for the phytopathologist. | |
SU700103A1 (ru) | Способ моделировани спазма аккомодации | |
GB1199251A (en) | Cultivating Foot and Mouth Disease Virus | |
GB1065875A (en) | Measles vaccine attenuated through avian choric-allantoic membrane |